A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes
Conditions
- Patients With Type 2 Diabetes
Interventions
- DRUG: Fenofibrate/CoQ10
- DRUG: Fenofibrate/CoQ10
- DRUG: Fenofibrate/CoQ10
- DRUG: Fenofibrate/CoQ10
- DRUG: Fenofibrate/CoQ10
- DRUG: Fenofibrate/CoQ10
- DRUG: Fenofibrate/CoQ10
Sponsor
Solvay Pharmaceuticals